Navigation Links
Two-Year Follow up Data of NuBac® IDE Feasibility Study Was Presented at SAS Meeting
Date:6/1/2010

MARQUETTE, Mich., June 1 /PRNewswire/ -- Pioneer Surgical Technology, Inc. is pleased to announce that the clinical results of the two-year follow up on the NuBac IDE feasibility study patients was presented at the recent 10th annual meeting of The International Society for the Advancement of Spine Surgery (SAS) in New Orleans by Domagoj Coric, M.D., Chief, Department of Neurosurgery, Carolina's Medical Center.

The NuBac implant system is the only Nucleus Replacement device that utilizes an articulating inner ball and socket design that seeks to achieve load sharing and uniform stress distribution under various physiological loading conditions. The NuBac implant is made of PEEK-OPTIMA® material which offers well established biocompatibility, biodurability, excellent wear resistance and radiolucency.

Dr. Coric, a Principal Investigator of the NUBAC IDE study, states, "The 2-year follow up results on the feasibility study patients are very impressive. From a safety point, there were no implant expulsions in this study; which has been the main challenge for all other nucleus devices. I am pleased with the improvements I have seen in these patients' clinical outcomes as well."

NuBac became the first nucleus replacement device to gain FDA IDE pivotal study approval. Pioneer started the pivotal study early last year and has 20 study sites with over 40 investigators across the country. Chip Bao, PhD., Pioneer's CTO, states, "The enthusiasm we have received from the spine surgeons reflects their desire for a less invasive and less bridge-burning motion preservation device. This study will help us understand if we can meet their expectations. We are very fortunate to have so many prominent spine surgeons, both in private practice and major academic institutions, willing to participate in this IDE pivotal study."

Pioneer continues to market their other P3® motion preservation products in Europe; including the NuNec® artificial cervical disc and the BacJac® interspinous decompression device. "The results from our European experience give us a lot of excitement as we strive to enter the U.S. market with these products," states Dr. Bao.

About Pioneer Surgical Technology, Inc.

Pioneer® Surgical Technology, Inc. is a dynamic medical device firm founded in 1992. Pioneer's focus on innovation has resulted in over 130 U.S. and foreign patents, with numerous patents pending. The company has a comprehensive portfolio of orthopedic, spine and biologic systems. Pioneer entered the orthobiologics market with two acquisitions in 2007. Our Orthopaedic, Spine, and Biologic Divisions produce state of the art, cost-effective solutions for surgical procedures that have proven difficult or problematic for both surgeons and patients. Pioneer employs more than 270 people worldwide. For more information on Pioneer and its products visit www.pioneersurgical.com.


'/>"/>
SOURCE Pioneer Surgical Technology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont
2. OncoGenex Provides Update on Two-Year Survival Data from Ongoing Phase 1/2 Clinical Trial of OGX-011 in Non-Small Cell Lung Cancer
3. Pepsi Urged to Follow Example of Coca-Cola and Stop Hiding Corporate Donations
4. HSC Trial Shows Continued Significant Hair Growth at One Year Follow-up
5. NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company
6. China Integrated Energy, Inc. Announces Eight Million Share Public Follow-On Offering
7. Alexandria Real Estate Equities, Inc. Announces Public Follow-on Offering of 3,000,000 Shares of Common Stock
8. Model predicts evolution of Mediterranean landscape following fires
9. Signostics Closes Follow-On Financing of US$4 Million, Expands Board of Directors
10. Alexandria Real Estate Equities, Inc. Announces Pricing of Public Follow-On Offering of 7,000,000 Shares of Common Stock
11. Corn Growers Reminded to Follow Refuge Requirements as Spring Planting Nears
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... ... April 18, 2017 , ... ... been a key device for generating monodisperse droplets of known diameters for research ... for generating monodisperse solid particles by drying monodisperse droplets. , The VOAG ...
(Date:4/19/2017)... ... April 19, 2017 , ... Nobilis Therapeutics Announces ... Seeks to Leverage Clinical Data in its Upcoming Post Traumatic Stress Disorder Trial , ... 81 patient clinical trial assessing efficacy of its NBTX-001, a xenon-based therapeutic in the ...
(Date:4/19/2017)... , April 19, 2017 A new report published by ... Forecast, 2014-2022 ," the global market was valued at $6,769 million in 2015, ... 9.6% from 2016 to 2022. ... Allied Market Research Logo ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) The ...
(Date:4/19/2017)... Mass. , April 19, 2017   ... results from the multi-center Procalcitonin MOnitoring SEpsis (MOSES) ... print issue of Critical Care Medicine . ... Mortality in Severe Sepsis Patients: Results From the ... use of the B·R·A·H·M·S PCT (procalcitonin) assay to ...
Breaking Biology Technology:
(Date:4/11/2017)... , April 11, 2017 No ... but researchers at the New York University Tandon ... of Engineering have found that partial similarities between ... systems used in mobile phones and other electronic ... The vulnerability lies in the fact ...
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
(Date:3/30/2017)... NEW YORK , March 30, 2017 ... by type (physiological and behavioral), by technology (fingerprint, AFIS, ... recognition, voice recognition, and others), by end use industry ... travel and immigration, financial and banking, and others), and ... Europe , Asia Pacific ...
Breaking Biology News(10 mins):